Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Phase IIa Double-Blind Placebo-Controlled Randomised Fourfold Cross-Over Study to Investigate the Glucose Lowering Effects of Dextromethorphan and Amantadine in Subjects with Type 2 Diabetes Mellitus T2DM after an Oral Glucose Tolerance Test

The purpose of this trial is to demonstrate that dextromethorphan DXM and amantadine compared to placebo exert blood glucose BG lowering effects following an oral glucose tolerance test OGTT in male subjects with T2DM

FieldValue
Modified
2020-01-22
Release Date
2018-05-12
Identifier
31f08b9a-3d8f-4abd-b5d5-71395423bb7d
License
Public Access Level
Public